# Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study

> **NCT04426084** · — · UNKNOWN · sponsor: **Karolinska Institutet** · enrollment: 22784 (actual)

## Conditions studied

- COVID-19

## Interventions

- **OTHER:** Hypertension
- **OTHER:** Diabetes type 2
- **OTHER:** Obesity
- **DRUG:** Antihypertensive Agents
- **DRUG:** Statins (Cardiovascular Agents)
- **OTHER:** Chronic kidney disease

## Key facts

- **NCT ID:** NCT04426084
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2021-06-08
- **Final completion:** 2023-12-31
- **Target enrollment:** 22784 (ACTUAL)
- **Last updated:** 2022-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04426084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04426084, "Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04426084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*